Rayno Life Science Market Update: CELG, ONXX, XBI Update 1
Sell-off gets worse with S&P down 2%. Moody's downgrade of banks expected by end of day. Bear market for commodities? ----------- We have been at BIO 2012 in Boston over the past week and will provide interesting trends and data from the Meeting by Monday. Global Slowdown Fears: Market off...
ASCO Week News Summaries
Here are some other good ASCO News sources from MedAdNews: PharmAviary provides a round up of the industry tweets of the week. Chris Truelove, editor in chief of Med Ad News and R&D Directions, scours the healthcare blogosphere to bring you a digestible summary of the big trends and issues...
Very Limited ASCO Boost For Biotechnology Stocks – Update 1 PCYC
A Biopharma Stock We Missed-Pharmacyclics (PCYC $38.21) up 9.89% today It is unbelievable that we missed the huge move in PCYC up 157% YTD with a one year range of 7.63 to 38.56. The market cap is $2.63B. The Company has a robust pipeline of products led by Ibrutinib, a Bruton tyrosine kinase...
Rayno Life Science Portfolio Gets ASCO Boost With Antibody Drug Conjugates
Antibody Drug Conjugates Make Progress for Cancer Therapy- Immunogen and Seattle Genetics Many of our focus stocks were up today helped by a late day rally that brought the NASDAQ up 0.46% at the close. Major biotechnology ETF's (IBB,XBI) also recovered with some green by the end of the day.The...
MO Gang Taking Profits With Risk OFF
Jobs Number Spooks Traders-Dow Erases Gains for the Year Large cap biotechnology and MO growth stocks are taking a big hit today as hedgies take profits. Many of these stocks are still up YTD but profits are quickly eroding. Stocks to watch in technology, retail and biotechnology are :Intuitive...